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Supplementary Figure S1. Plasmid map of pCS1748. RNA devices are inserted in the 3’ UTR 
of yEGFP3. 
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Supplementary Figure S2. Library design for sN10 sensor, aN7 actuator, and tN11 and a1-tN11 
transmitter libraries. Predicted secondary structures of the active ribozyme conformation with 
unbound theophylline aptamer (left) and the inactive ribozyme conformation with bound 
theophylline aptamer (right) are shown. The sequence for the L2b8 parent device is shown. 
Nucleotides that comprise the sensor, actuator, and transmitter components are colored blue, 
black, and yellow, respectively. Theophylline is represented by the red polygon. Filled circles 
within each component indicate nucleotides randomized to generate respective device libraries. 
Secondary structures were predicted by RNAstructure folding software (43) and rendered using 
VARNA software (44). 
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(A) 
 GFP (A.U.) mCherry (A.U.) Viability (%) 
 0mM Theo 5mM Theo Ratio 0mM Theo 5mM Theo Ratio 0mM Theo 5mM Theo Ratio 
Replicate 1 3969.31 4532.12 1.14 2097.92 2339.26 1.12 98.24 97.16 0.99 
Replicate 2 6282.93 6868.85 1.09 2699.57 2589.77 0.96 97.51 96.60 0.99 
Replicate 3 2960.27 3129.06 1.06 2505.69 2496.95 1.00 96.47 96.73 1.00 
Mean ± S.D.   1.10 ± 0.04   1.02 ± 0.08 97.41 ± 0.89 96.83 ± 0.29 0.99 ± 0.01 
 0mM Theo 40mM Theo Ratio 0mM Theo 40mM Theo Ratio 0mM Theo 40mM Theo Ratio 
Replicate 1 4687.84 6380.01 1.36 5653.65 5504.26 0.97 97.63 96.62 0.99 
Replicate 2 4777.71 6249.37 1.31 5137.39 5502.14 1.07 98.39 96.59 0.98 
Replicate 3 4878.88 5977.69 1.23 4722.92 4921.71 1.04 97.99 94.83 0.97 
Mean ± S.D.   1.30 ± 0.07   1.03 ± 0.05 98.00 ± 0.38 96.01 ± 1.02 0.98 ± 0.01 
 0mM Tc 1mM Tc Ratio 0mM Tc 1mM Tc Ratio 0mM Tc 1mM Tc Ratio 
Replicate 1 2585.21 2382.28 0.92 2791.13 2278.18 0.82 98.05 98.72 1.01 
Replicate 2 2310.21 2036.61 0.88 2896.15 2628.35 0.91 97.73 98.74 1.01 
Replicate 3 2326.70 2203.89 0.95 3694.26 3691.82 1.00 97.75 98.22 1.00 
Mean ± S.D.   0.92 ± 0.03   0.91 ± 0.09 97.84 ± 0.18 98.56 ± 0.29 1.01 ± 0.00 
 
(B)    
 
 
Supplementary Figure S3. Quantification of nonspecific ligand effect on fluorescence intensity 
and cell viability. (A) Unnormalized data for GFP fluorescence, mCherry fluorescence, and cell 
viability for the positive control construct (sTRSV Contl, a noncleaving sTRSV ribozyme with a 
scrambled core) in all ligand conditions tested. Fluorescence values are reported as the geometric 
mean of the GFP or mCherry fluorescence of sTRSV Contl. Cell viability is reported as the 
percentage of cells included in the DAPI-(-) gate. Mean and standard deviation of three 
independent experiments are indicated. The ratio of fluorescence levels or cell viability 
percentages in the presence and absence of theophylline (theo) or tetracycline (tc) is indicated for 
each ligand condition. Variability in absolute GFP or mCherry signal among replicates for an 
individual ligand condition is due to differences in instrument calibration between experiments. 
Values for each replicate pair in the absence and presence of ligand were obtained in the same 
experiment with identical instrument calibration. (B) Scatter plots for sTRSV Contl under each 
ligand condition from a single representative experiment. 
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Supplementary Figure S4. Linear correlation between mCherry and GFP fluorescence for L2b1 
(A), L2b5 (B), and L2b8 (C) devices within the two-color construct. For each device, 2,000 cells 
are plotted from a single representative experiment at 0 and 5 mM theophylline (theo). Linear 
regression and R2 values are reported and support a distinct slope for different device gene-
regulatory activities. 
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Supplementary Figure S5. Screening of the sN10 sensor library based on a single-color output 
shows no enrichment of theophylline-responsive population after two sorting rounds. (A) The 
sN10 sensor library as described in Figure 3 is subjected to two sorting rounds based on the GFP 
output only. Each round consists of one negative sort in the absence of theophylline, followed by 
one positive sort in the presence of theophylline. For the negative sorts, the sorting gates are set 
by collecting the bottom 10% of the cell population after gating out the GFP-(-) population set by 
the negative-control construct, pCS4. For the positive sorts, the sorting gates are determined by 
overlapping the two GFP histograms of the L2b8 population in the absence and presence of 
theophylline. The gate was roughly set to enclose the non-overlaid part of the L2b8 population in 
the presence of theophylline. Percentage of cells collected in the sorting gate is indicated on each 
plot. At least 10 times the estimated library size was screened in each sort to ensure that the full 
library diversity was covered. (B) The enriched sensor library exhibits no population shift in 
response to theophylline, in contrast to the same library enriched from the two-color screen. This 
result suggests that the enrichment efficiency of the single-color screen is poor and additional 
sorting rounds would be necessary to recover the functional sequence. 
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Supplementary Figure S6. The two-color sorting strategy supports separation of 
autofluorescent and low expression cell populations. sTRSV (the active ribozyme control) 
exhibits ~1.2% normalized GFP fluorescence, relative to a noncleaving ribozyme positive 
control (sTRSV Contl) with a scrambled core. (A) A cell population harboring the sTRSV 
construct exhibits low fluorescence levels that overlap significantly with a cell population 
harboring no fluorescence reporter gene in the single-color histogram. (B) The sTRSV and 
autofluorescent populations separate based on mCherry expression in the two-color plot, 
allowing cells exhibiting low GFP expression due to stringent device gene-regulatory activity to 
be effectively enriched through two-color sorting. 
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Supplementary Figure S7. An actuator sort preserves switching activity in 6 out of 8 
characterized devices. Basal activity of the parent device, L2b8, is indicated by a dashed line. 
Gene-regulatory activities are reported as the geometric mean of the GFP fluorescence of the 
indicated sample normalized to that of a positive control (sTRSV Contl, a noncleaving sTRSV 
ribozyme with a scrambled core) that is grown under identical ligand conditions and is set to 
100%. Reported values are the mean and standard deviation of at least three independent 
experiments. The activation ratio (AR) is determined as the ratio of gene expression levels in the 
presence and absence of theophylline (theo). 
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Supplementary Figure S8. Point mutation analyses of variant loop I sequences identify 
consensus sequences of ribozyme variants supporting improved gene-regulatory activities. The 
impact of point mutations to the recovered loop I sequences on basal activity was measured by 
flow cytometry. Relative expression levels are reported as the geometric mean of the GFP 
fluorescence of the indicated sample normalized to that of the L2b8 parent device. Reported 
values are the mean and standard deviation of at least three independent experiments. Indicated 
consensus sequences support decreased basal activities relative to the L2b8 parent as discussed 
in the main text (AUNNARG and N1UNGGGN1|). 
 
Two putative loop I consensus sequences were supported from the sequences recovered from the 
actuator library screen: a heptaloop (AUYNRRG) and a triloop (NUYGGGN|). Analysis of the 
point mutants made to interrogate nucleotide base constraints at each position of the heptaloop 
sequence found that any base (N) is tolerable at the third and fourth positions, but specific 
identities at the third position result in improved basal activity (C > A/U > G). The fifth and sixth 
positions accept both purine bases (A, G) and retain activity similar to that of the L2b8 parent; 
however, an adenine base (A) in the fifth position results in improved basal activity. Point 
mutants verified the requirement of a guanine base (G) in the seventh position. 
 
For the triloop sequence, point mutants indicate that any combination of bases in the first and 
seventh positions resulting in canonical Watson-Crick base pairing (AU, GC; order independent) 
results in improved basal activity. The bases in the second and sixth positions must result in a 
Watson-Crick GU wobble pair, where this requirement is sensitive to identity and order (i.e., 
standard Watson-Crick pairing abolishes improved activity). The point mutants indicate that the 
third position is able to accept any nucleotide base (N), whereas a guanine base (G) is required at 
the fourth and fifth positions to retain improved activity relative to the L2b8 parent device. 
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(A) L2b1: 
	  
 
(B) L2b5: 
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(C) L2b8: 
 
  
(D) L2b8-a1: 
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(E) L2b8-a14:	  
  
 (F) L2b8-a1-t41: 
 
 
(G) sTRSV ribozyme:  
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(H) 
RNA Device Cleavage Rate (k, min-1) 
0 mM theophylline 5 mM theophylline 
L2b1 0.033 ± 0.008 0.011 ± 0.003 
L2b5 0.013 ± 0.002 0.007 ± 0.001 
L2b8 0.14 ± 0.02 0.025 ± 0.009 
L2b8-a1 0.70 ± 0.3 0.10 ± 0.03 
L2b8-a14 1.4 ± 0.1 0.33 ± 0.01 
L2b8-a1-t41 0.16 ± 0.05 0.096 ± 0.02 
sTRSV ribozyme 4.3 ± 0.8 4.3 ± 1.4 
 
Supplementary Figure S9. Representative cleavage assays for measuring cleavage rate 
constants (k) for ribozyme-based devices and controls. A representative assay is shown for each 
device in the absence and presence (0 and 5 mM, respectively) of theophylline: L2b1 (A), L2b5 
(B), L2b8 (C), L2b8-a1 (D), L2b8-a14 (E), L2b8-a1-t41 (F), and sTRSV ribozyme (G). Bands 
for both the cleaved products (5’C, 3’C) and the full-length uncleaved substrate (UC) are shown 
for L2b1. For subsequent devices, the shorter 5’C product is omitted from the inset image for 
clarity. Methods used to prepare full-length, uncleaved RNA transcripts and conditions of the 
cleavage assays are detailed in the Materials and Methods section of the main text. Briefly, RNA 
was heated to 95°C for 5 min and cooled to 37°C in a secondary structure refolding buffer (100 
mM NaCl, 50 mM Tris-HCl (pH 7.5)). A zero time point aliquot was removed prior to initiating 
the reaction with addition of MgCl2 to a final concentration of 500 µM. Reactions were quenched 
at the indicated time points. At least seven time points were taken in each cleavage assay to 
capture the cleavage dynamics of RNA devices exhibiting different cleavage kinetics.  A black 
vertical bar was used to denote time points run on different gels. Phosphorimaging analysis of 
relative levels of the UC, 5’C, and 3’C bands was used to determine the fraction cleaved at each 
time point (Ft). The fraction cleaved at the beginning (F0) and end of reaction (F∞) varied 
between assays, but all assays were well-fit to the single exponential equation (R2 > 0.95): 
 
Ft = F0 + (F∞ − F0 )×(1 – e−kt) 
 
The black and red fit lines represent assays performed at 0 and 5 mM theophylline, respectively. 
The cleavage rate constant value (k) was determined for each assay. The reported k for each 
device and theophylline assay condition is the mean and standard deviation of at least three 
independent experiments (H). 
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Supplementary Figure S10. Increased input ligand concentration results in higher device ON 
states. Increasing ligand concentration to 40 mM theophylline (theo) increases device activation 
ratio (AR) compared to 5 mM theophylline. Gene-regulatory activities are reported as the 
geometric mean of the GFP fluorescence of the indicated sample normalized to that of a positive 
control (sTRSV Contl, a noncleaving sTRSV ribozyme with a scrambled core) that is grown 
under identical ligand conditions and is set to 100%. Reported values are the mean and standard 
deviation of at least three independent experiments. The activation ratio (AR) is determined as 
the ratio of gene expression levels in the presence and absence of theophylline (theo). 
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Supplementary Figure S11. Gene-regulatory activities of the optimized actuator components 
are maintained in the context of different sensor and transmitter components. Replacement of the 
loop I sequence with the a1 or a14 sequence decreases basal activity in all devices tested, 
including theophylline (theo)-responsive ON (A, B) and OFF (C) switches and a tetracycline-
responsive ON switch (D). Switching activity is maintained in most devices. Notably, 
replacement of the loop I sequence in the sTRSV ribozyme (E) significantly increases basal 
activity. Gene-regulatory activities are reported as the geometric mean of the GFP fluorescence 
of the indicated sample normalized to that of a positive control (sTRSV Contl, a noncleaving 
sTRSV ribozyme with a scrambled core) that is grown under identical ligand conditions and is 
set to 100%. Reported values are the mean and standard deviation of at least three independent 
experiments. The activation ratio (AR) is determined as the ratio of gene expression levels in the 
presence and absence of theophylline (theo) (A, B, C) or of tetracycline (D). 
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(A) L2b8 parent (Loop I: UGUGCUU) 
  
 
(B) aN7 heptaloop consensus (AUNNARG) 
  
 
 
 
 
 
 
 
 
 
 
 
(C) Newt hammerhead ribozyme 
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(D) aN7 triloop consensus (N1UN2GGGN1|) 
  
(E) CarSVRNA(-) hammerhead ribozyme 
  
 
Supplementary Figure S12. Secondary structure analysis indicates similarities between 
engineered RNA devices and natural hammerhead ribozymes (HHRzs). The HHRz invariant 
nucleotide bases are boxed in black, and the cleavage site is denoted by an arrow in all 
structures. In RNA device structures (A, B, D), nucleotide bases of the transmitter and aptamer 
domains are boxed in grey and olive green respectively. Using the common numbering system 
for HHRz with apical loops (45), nucleotide bases highlighted in cyan (L1.1 U) and red (L1.6 U) 
are those conforming to the common HHRz loop I motif, UNmYN, where m is typically 3 or 4 
bases. Common loop II motif nucleotide bases, (RNnA), are highlighted in yellow (L2.1 G) and 
orange (L2.1 A), where n is usually 2 or 4 bases (36). R and Y denote purine and pyrimidine 
bases respectively. (A) The HHRz core of the L2b8 parent device forms a predicted GU base 
pair at L2.2-L2.3 due to transmitter-sensor integration into loop II when analyzed by 
RNAstructure folding software (43). HHRz loop sequence similarities exist between a device 
containing the variant heptaloop consensus sequence selected in this study (B) and the newt 
HHRz (C). In loop I, both HHRz structures have AU in the first two positions 5’ from the 
catalytic core (boxed in green) and RG in last two positions (boxed in brown). In loop II, both 
structures have a G nucleotide not constrained in a Watson-Crick base pair (circled in cyan). 
Loop sequence similarities also exist between a device containing the variant triloop consensus 
sequence (D) and the CarSVRNA(-) HHRz (E). Both loop I sequences in these HHRzs contain a 
triloop with a GU base pair closing the loop (circled in purple) and accommodate GG in the first 
two positions 5’ from the catalytic core (boxed in green). In loop II, both HHRz structures have 
L2.1 G and L2.4 A nucleotides not constrained in Watson-Crick base pairs, available for loop I-
loop II interaction, circled in cyan (36). Secondary structures rendered using VARNA software 
(44). 
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Supplementary Table S1. Summary of plasmids constructed. 
 
Plasmid   Color Controls 
pCS1748  two-color screening plasmid: TEF1p-GFP-ADH1t and TEF1p-mCherry-CYC1t 
pCS1585  single-color plasmid: TEF1p-GFP-ADH1t 
pCS1749   single-color plasmid: TEF1p-mCherry-CYC1t 
    Ribozyme-based Devices and Controls 
pCS1750  pCS1748+sTRSV 
pCS1751  pCS1748+sTRSV Contl 
pCS1752  pCS1748+L2b1 
pCS1753  pCS1748+L2b8 
pCS2260  pCS1748+L2b5 
pCS2261  pCS1748+L2b8-a1 
pCS2262  pCS1748+L2b8-a6 
pCS2263  pCS1748+L2b8-a9 
pCS2264  pCS1748+L2b8-a10 
pCS2265  pCS1748+L2b8-a11 
pCS2266  pCS1748+L2b8-a12 
pCS2267  pCS1748+L2b8-a14 
pCS2268  pCS1748+L2b8-a27 
pCS2269  pCS1748+L2b8-t11 
pCS2270  pCS1748+L2b8-t24 
pCS2271  pCS1748+L2b8-t47 
pCS2272  pCS1748+L2b8-t197 
pCS2273  pCS1748+L2b8-t241 
pCS2274  pCS1748+L2b8-a1-t41 
pCS2275  pCS1748+L2b8-a1-t55 
pCS2276  pCS1748+L2b8-a1-t64 
pCS2277  pCS1748+L2b1-a1 
pCS2278  pCS1748+L2b1-a14 
pCS2279  pCS1748+L2b5-a1 
pCS2280  pCS1748+L2b5-a14 
pCS2281  pCS1748+L2bOFF1 
pCS2282  pCS1748+L2bOFF1-a1 
pCS2283  pCS1748+L2bOFF1-a14 
pCS2284  pCS1748+L2b8tc 
pCS2285  pCS1748+L2b8tc-a1 
pCS2286  pCS1748+L2b8tc-a14 
pCS2287  pCS1748+sTRSV-a1 
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pCS2288  pCS1748+sTRSV-a14 
pCS2289  pCS1748+L2b8-a1-t11 
pCS2290  pCS1748+L2b8-a1-t47 
pCS2291   pCS1748+L2b8-t41 
 
